hydroxychloroquine has been researched along with Takayasu Arteritis in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Takayasu Arteritis: A chronic inflammatory process that affects the AORTA and its primary branches, such as the brachiocephalic artery (BRACHIOCEPHALIC TRUNK) and CAROTID ARTERIES. It results in progressive arterial stenosis, occlusion, and aneurysm formation. The pulse in the arm is hard to detect. Patients with aortitis syndrome often exhibit retinopathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the benefits of HCQ in the treatment of Takayasu arteritis (TA) remain unclear, especially in terms of alleviation of vascular progression." | 5.62 | Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis. ( Jiang, L; Lili, M; Lindi, J; Lingying, M; Rongyi, C; Sifan, W; Wenshu, Y; Xiaomeng, C; Xiaomin, D; Xiufang, K; Yanshan, L; Ying, S; Zongfei, J, 2021) |
| "However, the benefits of HCQ in the treatment of Takayasu arteritis (TA) remain unclear, especially in terms of alleviation of vascular progression." | 1.62 | Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis. ( Jiang, L; Lili, M; Lindi, J; Lingying, M; Rongyi, C; Sifan, W; Wenshu, Y; Xiaomeng, C; Xiaomin, D; Xiufang, K; Yanshan, L; Ying, S; Zongfei, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rongyi, C | 1 |
| Zongfei, J | 1 |
| Jiang, L | 2 |
| Sifan, W | 1 |
| Lingying, M | 1 |
| Ying, S | 1 |
| Wenshu, Y | 1 |
| Xiaomeng, C | 1 |
| Xiufang, K | 1 |
| Xiaomin, D | 1 |
| Lili, M | 1 |
| Yanshan, L | 1 |
| Lindi, J | 1 |
| Sun, Y | 1 |
| Ma, L | 1 |
| Chen, H | 1 |
| Kong, X | 1 |
| Lv, P | 1 |
| Dai, X | 1 |
| Ji, Z | 1 |
| Yang, C | 1 |
| Dai, S | 1 |
| Wu, L | 1 |
| Zou, Y | 1 |
| Lin, J | 1 |
| Shi, H | 1 |
| Yu, Q | 1 |
2 other studies available for hydroxychloroquine and Takayasu Arteritis
| Article | Year |
|---|---|
Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis.
Topics: Angiography; Blood Sedimentation; Humans; Hydroxychloroquine; Longitudinal Studies; Retrospective St | 2021 |
Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
Topics: Adult; Age Factors; Benzimidazoles; Blood Sedimentation; C-Reactive Protein; China; Cyclophosphamide | 2018 |